Bhandari Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Bhandari Labs
Bhandari Labs Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 August 2020 (Four years and six months 20 days old ). Its registered office is in Ujjain, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Meet Bhandari, Anoop Shah, Shubham Jain, and One other member serve as directors at the Company.
Company Details
- Location
Ujjain, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290MP2020PTC052206
- Company No.
052206
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2020
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Bhandari Labs?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meet Bhandari  | Director | 07-Aug-2020 | Current |
| Anoop Shah | Director | 19-Jul-2023 | Current |
| Shubham Jain | Director | 19-Jul-2023 | Current |
| Naresh Bhandari | Director | 07-Aug-2020 | Current |
Financial Performance of Bhandari Labs.
Bhandari Labs Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bhandari Labs?
In 2021, Bhandari Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Virat Infusions Private LimitedMeet Bhandari and Naresh Bhandari are mutual person
- Shri Shivansh (Ujjain) Infracon Private Limited
Naresh Bhandari is a mutual person
- Suparshva Realities Private Limited
Naresh Bhandari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bhandari Labs?
Bhandari Labs has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhandari Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhandari Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.